or Try an Advanced Search...

    Experimental Cancer Treatments Stocks List

    Symbol Grade Name % Change
    REPL B Replimune Group, Inc. 1.19
    GNLX C Genelux Corporation -0.31
    AGEN F Agenus Inc. -3.57
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Clinical Medicine Medicine Biotechnology Immunotherapy Non Small Cell Lung Cancer Oncolytic Virus Transgene Sa Virotherapy Akseli Hemminki Alzheimer's Disease Biopharmaceutical Cancer Treatment Cancer Vaccine Carcinoma Genital Herpes Glioma Herpes Immune System Immunotherapies

    Related ETFs - A few ETFs which own one or more of the above listed Experimental Cancer Treatments stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.87
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.0
    MEDX D Horizon Kinetics Medical ETF 0.99
    PTH D Invesco DWA Healthcare Momentum ETF 0.79
    SBIO B ALPS Medical Breakthroughs ETF 0.53
    View all Experimental Cancer Treatments ETFs...
    Compare ETFs
    Compare BBC to PTH Compare CNCR to MEDX Compare MEDX to PTH

        Experimental Cancer Treatments Stocks Recent News

        Date Stock Title
        Oct 31 GNLX Genelux: H2 2025 PRROC Data Is A Major Inflection Point
        Oct 31 GNLX Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well
        Oct 30 REPL Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
        Oct 29 GNLX Genelux started at buy by Guggenheim ahead of Olvi-vec data
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Clinical Medicine Medicine Biotechnology Immunotherapy Non Small Cell Lung Cancer Oncolytic Virus Transgene Sa Virotherapy Akseli Hemminki Alzheimer's Disease Biopharmaceutical Cancer Treatment Cancer Vaccine Carcinoma Genital Herpes Glioma Herpes Immune System Immunotherapies
        Experimental Cancer Treatments

        Experimental cancer treatments are treatments that are being tested in clinical trials to determine their safety and effectiveness in treating cancer. These treatments may include new drugs, new combinations of drugs, new surgical procedures, or new ways to use existing treatments.

        Browse All Tags